Close Menu

The 2012 meeting of the Association of Biomolecular Resource Facilities opened Saturday evening in Orlando, Fla., with a keynote address from the University of Washington's Trisha Davis. In her talk, Davis discussed the evolution of the Yeast Resource Center at UW from its early days of taking a broad approach, to focusing its work, to then widening its offerings once again. Yeast is "good for technology development," she said.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The US Food and Drug Administration is to announce stricter standards for emergency authorizations of SARS-CoV-2 vaccines, reports the Washington Post.

The Associated Press reports Johnson & Johnson is starting a late-stage clinical trial of its candidate SARS-CoV-2 vaccine.

Bloomberg reports the budget of Operation Warp Speed is actually $18 billion, higher than the number typically cited.

In Genome Research this week: genomic analysis reveals role of super-spreaders in SARS-CoV-2, epigenetic drivers of cancer, and more.